L6 Cheat sheet Flashcards

1
Q

What are some key articular cells involved in the pro-inflammatory actions of TNF in rheumatoid arthritis?

A

Monocytes, T cells, B cells, NK cells, neutrophils, mast cells, synovial fibroblasts, and osteoblasts.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What do articulatr cells refer to

A

refers to the important types of cells found within or around a joint (play a role in joint function, maintenance and inflammation in disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When was the first anti-TNF drug approved for rheumatoid arthritis?

A

1998

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how effective are anti - TNF drugs for treating rheumatoid arthritis

A

effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the main functions of TNF in rheumatoid arthritis

A

↑ Monocyte activation, cytokine release

↑ Neutrophil priming, oxidative burst, apoptosis

↑ Inappropriate T cell activation and apoptosis

↑ Endothelial cell expression of adhesion molecules (e.g. ICAM-1 and VCAM-1)

↑ Fibroblast MMP (MMP1, MMP3, MMP13) and cytokine release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some key articular cells involved in the pro-inflammatory actions of IL-6 in rheumatoid arthritis?

A

monocytes, macrophages, B cells, Mast cells, Synovial fibroblasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how effective are anti IL_6 drugs for treating rheumatoid arthritis

A

effective `

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

when was the first anti IL-6R drug approved for rheumatoid arthritis

A

2010

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

which drugs related to IL_6 and rheumatoid arthritis are currently in clinical trial

A

anti IL-6 drugs (in clinical trials) and sgp130-fc (early clinical trial)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the main functions of IL-6 in rheumatoid arthritis

A

↑ B cell proliferation and antibody production

↑ T cell proliferation, differentiation, trafficking, effector function and survival

↑ Hepatic acute-phase response (systemic inflammation)

↑ Angiogenesis (↑ VEGF expression)

↑ Osteoclast (bone resorbing cell) differentiation via induction of RANKL expression

↑ Fibroblast MMP and cytokine release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some key articular cells involved in the pro-inflammatory actions of IL-17 in rheumatoid arthritis?

A

Th17 cells, ɣδ T cells (gamma delta T cells), NK and NKT cells
and Synovial fibroblasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how effective are anti IL-17 drugs in clinical trials against rheumatoid arthritis

A

low efficacy (although effective for psoriatic arthritis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are current trials testing for in terms of IL-17 and rheumatoid arthritis

A

Current trials testing efficacy in patients that show poor response to anti-TNF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the main functions of IL-17 in rheumatoid arthritis

A

↑ Leukocyte recruitment (e.g. neutrophils)

↑ Osteoclast differentiation (osteoclastogenesis) via induction of RANKL expression

↑ Fibroblast MMP (MMP1, MMP9, MMP13) and cytokine release

↑ Angiogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some key articular cells involved in the pro-inflammatory actions of IL-1 in rheumatoid arthritis?

A

Monocytes, B cells, Synovial fibroblasts and chondrocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

when was Anakinra ( Engineered version of soluble IL-1R antagoinst) first approved for rheumatoid arthritis

17
Q

how effective are anti IL-1 drugs against rheumatoid arthritis

A

Not recommended. Limited use due to lower efficacy than other biological drugs

18
Q

What does the failure of IL-1 blockade in rheumatoid arthritis suggest about its role in synovial processes?

A

The failure does not imply IL-1 lacks a functional role in synovial processes but rather that it does not play a pivotal regulatory role in the inflammatory cascade. Many effector pathways leading to symptoms are potentially mediated by IL-1, often working synergistically with TNF. These include prostanoid synthesis and the activation of chondrocytes and fibroblast-like synoviocytes (FLSs).

19
Q

What are some key articular cells involved in the pro-inflammatory actions of RANKL in bone erosion / rheumatoid arthritis?

A

Osteoblasts, CD4+ T cells (Th17, Th1 cells, synovial fibroblasts)

20
Q

what have phase II trials shows about anti RANKL

A

that it is safe and limits progression of joint destruction

21
Q

what is the main function of RANKL

A

↑ Bone resorption via osteoclast differentiation, maturation and activation.

22
Q

What are osteoclasts and how do they function?

A

Osteoclasts stick to and digest underlying bone minerals by releasing acids and collagenases.

23
Q

What is the process by which osteoclasts differentiate?

A

through a cytokine driven process

24
Q

What are the essential cytokine mediators involved in osteoclast differentiation?

A

The essential cytokine mediators are RANKL (Receptor Activator of Nuclear Factor-κB ligand) and M-CSF (Macrophage Colony-Stimulating Factor), expressed by synovial fibroblasts and T helper cells.

25
Q

What cytokines support osteoclast differentiation?

A

TNF (Tumour Necrosis Factor), IL-1 (Interleukin-1), IL-17 (produced by TH17 cells), and IL-7 (produced by synovial fibroblasts) support osteoclast differentiation.

26
Q

Which cytokines inhibit osteoclast differentiation?

A

IL-4, IL-10, GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor), and IFNγ (Interferon-gamma) inhibit osteoclast differentiation.

27
Q

What role do TH cells play in osteoclast differentiation?

A

T helper cells produce cytokines that either support or inhibit osteoclast differentiation, with TH1 cells producing RANKL, M-CSF, TNF, IL-1, GM-CSF, and IFNγ, and TH17 cells producing IL-17.

28
Q

How does osteoclast differentiation differ in rheumatoid arthritis?

A

In rheumatoid arthritis, the differentiation of osteoclasts from haematopoietic osteoclast precursors is driven by cytokines like RANKL and M-CSF, with additional cytokines like TNF, IL-1, and IL-17 playing a key role in the process.